The conversation is about the delay in the release of GT20029 phase 2 results by Kintor. It also mentions Minoxidil, finasteride, and RU58841 as treatments for hairloss.
The conversation introduces a specialized chatbot for ChatGPT Plus users that provides advice on hairloss treatments, drawing from research and community insights. It mentions treatments like RU58841, the "big 4" (likely minoxidil, finasteride, ketoconazole, and tretinoin), dutasteride mesotherapy, topical melatonin, microneedling, and rapamycin.
The conversation compares Finasteride and Dutasteride for hairloss treatment, discussing their effectiveness and side effects. Users share personal results and consider combining treatments like Dutasteride with RU58841.
The conclusion of this conversation about hairloss is that the user "its_zi" has been using a combination of minoxidil, finasteride, dutasteride, and RU58841, along with microneedling, and has seen great results in regrowing hair. They plan to continue the treatment and consider a hair transplant in the future.
The user has been treating hairloss for 5 years and currently uses 0.5mg dutasteride, 5mg oral minoxidil, and 10,000mcg biotin daily, experiencing the best growth in years without the side effects they had on finasteride. Suggestions from others include starting microneedling, with one comment noting minimal visible hair regrowth.
A user's experience with hairloss treatments, specifically Minoxidil and finasteride, which they have used without side effects for a year. Other users shared their experiences and advice about potential side effects and supplements to help.
A user shared their experience with Finasteride for hairloss, noting a significant reduction in DHT levels and a complete loss of libido without other side effects. Another user agreed, discussing the negative impact on sexual drive and criticizing the community's attitude towards discussing side effects.
User "missbloombastic" has been experiencing hairloss since 2016 and tried min, fin, multivitamins, and spiro with mixed results. Another user shares their struggle with hairloss and its impact on self-esteem, while a third user suggests checking blood tests and confirming the cause of hairloss.
User tried DIY Dutasteride Mesotherapy for hairloss due to unsatisfactory Finasteride results. Used mesotherapy injection gun and liquid dutasteride for better results and fewer side effects.
The user's experience with hairloss, their doctor explaining that they were likely hyper aware of thin spots due to anxiety and an underlying whorl in one area, and providing encouragement for those feeling discouraged. Treatments mentioned include minoxidil and spironolactone.
A 20-year-old is experiencing severe hairloss and is considering using dutasteride and finasteride, worried about potential side effects. They feel depressed and isolated due to hairloss, and are exploring options like hair transplants and hair systems but are hesitant about faking it.
A user considered using Nanoxidil for hairloss, applying it daily and dermarolling weekly, but stopped after a few months due to lack of motivation and minimal results. They experienced no irritation or side effects and decided against using finasteride.
A male with early-stage hairloss experienced severe side effects, including sexual dysfunction from finasteride and increased heart rate and fatigue from high-dose minoxidil, leading to discontinuation of both treatments. He is now relying on DHT-blocking shampoos and awaiting new treatments.
User jeperscrepers shared their six-month hairloss treatment routine, which includes 1mg finasteride daily, Costco brand Minoxidil foam twice a day, Nizoral shampoo, dermapen with Derminator II monthly, and various supplements. They reported significant hair regrowth and reduced thinning.
The conversation discusses skepticism about new hairloss treatments, with many users expressing doubt about their effectiveness compared to existing treatments like minoxidil and finasteride. Some users mention natural oils like olive and macadamia oil, but overall, there's a consensus that these are unlikely to be game changers.
The conversation discusses the potential updates on the pp405 trial for hairloss, with completion expected by December 2025. Participants express skepticism about new treatments, suggesting continued use of finasteride, while others hope for innovative solutions beyond current medications.
A 17-year-old experienced significant hairloss after switching from topical to oral minoxidil and adding finasteride. The recommendation is to return to topical minoxidil and continue with finasteride or consider dutasteride.
A 30-year-old male using finasteride for hairloss has high testosterone and estrogen levels but no side effects. He is advised to monitor hormone levels, consider dietary changes, and use additional treatments like vitamin D3, minoxidil, and dutasteride for hair growth.
GT20029 and KX826 are promising hairloss treatments, with GT20029 increasing hair count and KX826 showing significant results. KX826 may be a good alternative for those who can't use finasteride or dutasteride, though results vary.
Many people use finasteride and dutasteride for hairloss, with some switching due to cost or effectiveness. Minoxidil is also commonly used, and side effects like weaker erections or ball pain are reported by some.
Dutasteride is less commonly prescribed for hairloss because it is not FDA-approved for this purpose, unlike finasteride, which is more accessible and preferred due to fewer side effects. Dutasteride may be more effective in reducing DHT but has a longer half-life and potentially more significant side effects.
A user is struggling with hairloss at 17 and has been using finasteride for 5 months and minoxidil for 11 months without seeing regrowth. Other users encourage continuing treatment, sharing their own experiences with finasteride, minoxidil, and dermarolling, and emphasizing patience and acceptance.
Dutasteride is recommended over finasteride for severe hairloss, despite potential side effects. The original poster has been using various treatments for four months and is considering adding copper tripeptide-1.
A user expressed frustration about hairloss and its impact on their 20s, mentioning financial struggles and mental health concerns. Responses included advice on positive thinking, self-improvement, and seeking treatment options like Minoxidil and finasteride.
The user discusses their long struggle with hairloss, considering various treatments like hair transplants, hair systems, and natural methods such as micro-needling, vitamin supplements, and a healthy lifestyle. They express concerns about side effects from drugs like finasteride and ultimately lean towards using a hair system for better appearance and confidence.
A user started finasteride for hairloss and saw improvement, but is now experiencing shedding and thinning in new areas. They added Nizoral due to dandruff caused by finasteride. Replies suggest that shedding is normal around 6 months and advise to stick with the treatment.
The user successfully treated their hairloss using 1ml of minoxidil twice daily and dermarolling with a 1.5mm dermaroller once a week. They experienced noticeable results only after combining minoxidil with dermarolling, and they have not used finasteride.
A user shared a 14-month hairloss treatment update using dutasteride, minoxidil foam, a 1.5mm derma roller, and Nizoral, with noticeable hair regrowth and no side effects. The discussion highlights the effectiveness of microneedling in combination with topical treatments, with many users agreeing it significantly enhances results.
Quitting minoxidil can lead to significant hairloss, even in areas that were not thinning before, as hair becomes reliant on the treatment. Some users also report losing hair gains when stopping minoxidil despite taking finasteride.
The conversation is about whether creatine causes hairloss in individuals who are taking finasteride or dutasteride for hairloss. Some users report experiencing hairloss when taking creatine, while others do not. There is no consensus on the issue.